Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Change in Inventory (2017 - 2025)

Catheter Precision (VTAK) has disclosed Change in Inventory for 9 consecutive years, with -$4000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Inventory rose 66.67% to -$4000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $22000.0, a 269.23% increase, with the full-year FY2024 number at $8000.0, up 200.0% from a year prior.
  • Change in Inventory was -$4000.0 for Q3 2025 at Catheter Precision, up from -$18000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $154000.0 in Q3 2021 to a low of -$73000.0 in Q1 2022.
  • A 5-year average of $12000.0 and a median of $5000.0 in 2023 define the central range for Change in Inventory.
  • Peak YoY movement for Change in Inventory: skyrocketed 442.22% in 2021, then tumbled 621.43% in 2022.
  • Catheter Precision's Change in Inventory stood at -$65000.0 in 2021, then skyrocketed by 166.15% to $43000.0 in 2022, then tumbled by 146.51% to -$20000.0 in 2023, then skyrocketed by 105.0% to $1000.0 in 2024, then plummeted by 500.0% to -$4000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Change in Inventory are -$4000.0 (Q3 2025), -$18000.0 (Q2 2025), and $43000.0 (Q1 2025).